Logo image of BODI

BEACHBODY CO INC/THE (BODI) Stock Fundamental Analysis

NYSE:BODI - New York Stock Exchange, Inc. - US0734633094 - Common Stock - Currency: USD

8.345  +0.48 (+6.04%)

Fundamental Rating

1

Taking everything into account, BODI scores 1 out of 10 in our fundamental rating. BODI was compared to 71 industry peers in the Diversified Consumer Services industry. BODI has a bad profitability rating. Also its financial health evaluation is rather negative. BODI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year BODI has reported negative net income.
In the past year BODI had a positive cash flow from operations.
BODI had negative earnings in 4 of the past 5 years.
In multiple years BODI reported negative operating cash flow during the last 5 years.
BODI Yearly Net Income VS EBIT VS OCF VS FCFBODI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 -100M -200M

1.2 Ratios

BODI's Return On Assets of -45.29% is on the low side compared to the rest of the industry. BODI is outperformed by 81.25% of its industry peers.
BODI's Return On Equity of -174.94% is on the low side compared to the rest of the industry. BODI is outperformed by 78.13% of its industry peers.
Industry RankSector Rank
ROA -45.29%
ROE -174.94%
ROIC N/A
ROA(3y)-44.92%
ROA(5y)-25.96%
ROE(3y)-111.84%
ROE(5y)-64.11%
ROIC(3y)N/A
ROIC(5y)N/A
BODI Yearly ROA, ROE, ROICBODI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 -50 -100 -150

1.3 Margins

With a decent Gross Margin value of 66.55%, BODI is doing good in the industry, outperforming 79.69% of the companies in the same industry.
In the last couple of years the Gross Margin of BODI has declined.
The Profit Margin and Operating Margin are not available for BODI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.55%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.82%
GM growth 5Y-2.91%
BODI Yearly Profit, Operating, Gross MarginsBODI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 20 -20 40 60

More info and screens

1

2. Health

2.1 Basic Checks

BODI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BODI has been reduced compared to 1 year ago.
BODI has a worse debt/assets ratio than last year.
BODI Yearly Shares OutstandingBODI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 100M 200M 300M
BODI Yearly Total Debt VS Total AssetsBODI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

BODI has an Altman-Z score of -2.51. This is a bad value and indicates that BODI is not financially healthy and even has some risk of bankruptcy.
BODI has a worse Altman-Z score (-2.51) than 75.00% of its industry peers.
BODI has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.17, BODI is in line with its industry, outperforming 53.13% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z -2.51
ROIC/WACCN/A
WACC12.8%
BODI Yearly LT Debt VS Equity VS FCFBODI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 200M -200M

2.3 Liquidity

A Current Ratio of 0.64 indicates that BODI may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.64, BODI is doing worse than 75.00% of the companies in the same industry.
A Quick Ratio of 0.52 indicates that BODI may have some problems paying its short term obligations.
With a Quick ratio value of 0.52, BODI is not doing good in the industry: 81.25% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.64
Quick Ratio 0.52
BODI Yearly Current Assets VS Current LiabilitesBODI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 60.56% over the past year.
Looking at the last year, BODI shows a very negative growth in Revenue. The Revenue has decreased by -18.85% in the last year.
Measured over the past years, BODI shows a decrease in Revenue. The Revenue has been decreasing by -7.78% on average per year.
EPS 1Y (TTM)60.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.64%
Revenue 1Y (TTM)-18.85%
Revenue growth 3Y-15.17%
Revenue growth 5Y-7.78%
Sales Q2Q%-20.32%

3.2 Future

Based on estimates for the next years, BODI will show a very strong growth in Earnings Per Share. The EPS will grow by 22.80% on average per year.
The Revenue is expected to decrease by -10.87% on average over the next years. This is quite bad
EPS Next Y56.54%
EPS Next 2Y33.69%
EPS Next 3Y22.8%
EPS Next 5YN/A
Revenue Next Year-19.88%
Revenue Next 2Y-22.92%
Revenue Next 3Y-10.87%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BODI Yearly Revenue VS EstimatesBODI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
BODI Yearly EPS VS EstimatesBODI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 -5 -10 -15 -20 -25

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

BODI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BODI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BODI Price Earnings VS Forward Price EarningsBODI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

BODI's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.65
BODI Per share dataBODI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

A more expensive valuation may be justified as BODI's earnings are expected to grow with 22.80% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.69%
EPS Next 3Y22.8%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BODI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BEACHBODY CO INC/THE

NYSE:BODI (3/3/2025, 1:16:16 PM)

8.345

+0.48 (+6.04%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)11-12 2024-11-12/amc
Earnings (Next)03-18 2025-03-18/amc
Inst Owners40.81%
Inst Owner ChangeN/A
Ins Owners4.78%
Ins Owner Change0%
Market Cap57.75M
Analysts82
Price Target13.39 (60.46%)
Short Float %5.5%
Short Ratio14.56
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)36.99%
Min EPS beat(2)22.94%
Max EPS beat(2)51.05%
EPS beat(4)2
Avg EPS beat(4)10.71%
Min EPS beat(4)-24.55%
Max EPS beat(4)51.05%
EPS beat(8)3
Avg EPS beat(8)-7.43%
EPS beat(12)5
Avg EPS beat(12)-12.61%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.65%
Min Revenue beat(2)-2.88%
Max Revenue beat(2)-2.43%
Revenue beat(4)2
Avg Revenue beat(4)1.1%
Min Revenue beat(4)-2.88%
Max Revenue beat(4)7.28%
Revenue beat(8)3
Avg Revenue beat(8)0.26%
Revenue beat(12)6
Avg Revenue beat(12)2.8%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.13
P/FCF N/A
P/OCF 43.29
P/B 0.99
P/tB N/A
EV/EBITDA 15.65
EPS(TTM)-8.48
EYN/A
EPS(NY)-3.82
Fwd EYN/A
FCF(TTM)-0.54
FCFYN/A
OCF(TTM)0.19
OCFY2.31%
SpS65.24
BVpS8.44
TBVpS-5.97
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -45.29%
ROE -174.94%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.55%
FCFM N/A
ROA(3y)-44.92%
ROA(5y)-25.96%
ROE(3y)-111.84%
ROE(5y)-64.11%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.82%
GM growth 5Y-2.91%
F-Score5
Asset Turnover2
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA 3.57
Cap/Depr 10.81%
Cap/Sales 1.12%
Interest Coverage N/A
Cash Conversion 47.59%
Profit Quality N/A
Current Ratio 0.64
Quick Ratio 0.52
Altman-Z -2.51
F-Score5
WACC12.8%
ROIC/WACCN/A
Cap/Depr(3y)47.26%
Cap/Depr(5y)51.97%
Cap/Sales(3y)4.66%
Cap/Sales(5y)4.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)60.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.64%
EPS Next Y56.54%
EPS Next 2Y33.69%
EPS Next 3Y22.8%
EPS Next 5YN/A
Revenue 1Y (TTM)-18.85%
Revenue growth 3Y-15.17%
Revenue growth 5Y-7.78%
Sales Q2Q%-20.32%
Revenue Next Year-19.88%
Revenue Next 2Y-22.92%
Revenue Next 3Y-10.87%
Revenue Next 5YN/A
EBIT growth 1Y57.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year124.54%
EBIT Next 3Y29.92%
EBIT Next 5YN/A
FCF growth 1Y97.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y101.18%
OCF growth 3YN/A
OCF growth 5YN/A